Do Low-dose Corticosteroids Improve Survival or Shock Reversal from Septic Shock in Adults? Meta-analysis with Trial Sequential Analysis

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2018 Jun 19

PMID 29911468

Citations 7

Authors

Rui Xu

Qian Wang

Yan Huang

Ling Wu

Qi Liu

Wei Hu

Chengfu Zhou

Quan Du

Affiliations

Soon will be listed here.

Abstract

Objective This meta-analysis with trial sequential analysis (TSA) was performed to determine whether low-dose corticosteroids (LDCs) can improve survival or shock reversal from septic shock in adults. Methods A literature search was performed using several databases (Medline, Cochrane Library, Embase, and Chinese Biological Medical Database) until 23 October 2017. The systematic review was registered in PROSPERO. Results Nine randomized controlled trials (RCTs) (n = 1182) were included. LDC intervention improved 7-day shock reversal compared with the control group (relative risk, 1.36; TSA-adjusted 95% confidence interval, 1.20-1.54). LDCs had no statistically significant effects on gastrointestinal bleeding or superinfection. LDCs did not reduce 28-day mortality from septic shock (relative risk, 0.96; TSA-adjusted 95% confidence interval, 0.74-1.24). The TSA indicated that RCTs of about 3000 patients would be needed to draw definitive conclusions; similar results were obtained in a subgroup analysis of nonresponders. Conclusions LDCs improve 7-day shock reversal. However, whether LDCs improve 28-day survival from septic shock in adults remains unclear. The results of well-designed larger RCTs are needed.

Citing Articles

Epicardial adipose tissue in patients with chronic obstructive pulmonary disease: systematic review with meta‑analysis and trial sequential analysis.

Lan Y, Ma Q, Luo G, Yang H, Li Y, Zhang Q BMC Pulm Med. 2023; 23(1):241.

PMID: 37400821 PMC: 10318694. DOI: 10.1186/s12890-023-02535-z.

Effect of dexamethasone on intraoperative remifentanil dose in total knee arthroplasty surgery under general anaesthesia.

Gantzel M, Gasbjerg K, Hagi-Pedersen D, Meyhoff C, Olsen M, Mathiesen O Acta Anaesthesiol Scand. 2022; 66(9):1070-1076.

PMID: 35908167 PMC: 9543467. DOI: 10.1111/aas.14118.

Tocilizumab in patients infected by SARS-CoV2.

Sancho M, Muniz J, Cardinal-Fernandez P Med Clin (Engl Ed). 2021; 156(8):402-406.

PMID: 33763598 PMC: 7972641. DOI: 10.1016/j.medcle.2020.12.010.

Efficacy and safety of corticosteroids in immunocompetent patients with septic shock.

Lu X, Han W, Gao Y, Guo S, Yu S, Yu X World J Emerg Med. 2021; 12(2):124-130.

PMID: 33728005 PMC: 7947565. DOI: 10.5847/wjem.j.1920-8642.2021.02.007.

[Tocilizumab in patients infected by SARS-CoV2].

Sancho M, Muniz J, Cardinal-Fernandez P Med Clin (Barc). 2021; 156(8):402-406.

PMID: 33715841 PMC: 7843197. DOI: 10.1016/j.medcli.2020.12.003.

References

Annane D, Sebille V, Charpentier C, Bollaert P, Francois B, Korach J . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288(7):862-71. DOI: 10.1001/jama.288.7.862. View

Henley D, Lightman S, Carrell R . Cortisol and CBG - Getting cortisol to the right place at the right time. Pharmacol Ther. 2016; 166:128-35. DOI: 10.1016/j.pharmthera.2016.06.020. View

da Costa B, Juni P . Systematic reviews and meta-analyses of randomized trials: principles and pitfalls. Eur Heart J. 2014; 35(47):3336-45. DOI: 10.1093/eurheartj/ehu424. View

Oppert M, Schindler R, Husung C, Offermann K, Graf K, Boenisch O . Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005; 33(11):2457-64. DOI: 10.1097/01.ccm.0000186370.78639.23. View

Arabi Y, Aljumah A, Dabbagh O, Tamim H, Rishu A, Al-Abdulkareem A . Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010; 182(18):1971-7. PMC: 3001503. DOI: 10.1503/cmaj.090707. View

Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq P . Reduced cortisol metabolism during critical illness. N Engl J Med. 2013; 368(16):1477-88. PMC: 4413428. DOI: 10.1056/NEJMoa1214969. View

Gordon A, Mason A, Perkins G, Stotz M, Terblanche M, Ashby D . The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014; 42(6):1325-33. DOI: 10.1097/CCM.0000000000000212. View

Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2):165-228. PMC: 7095153. DOI: 10.1007/s00134-012-2769-8. View

Mathias B, Mira J, Larson S . Pediatric sepsis. Curr Opin Pediatr. 2016; 28(3):380-7. PMC: 4913352. DOI: 10.1097/MOP.0000000000000337. View

10.

Volbeda M, Wetterslev J, Gluud C, Zijlstra J, van der Horst I, Keus F . Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015; 41(7):1220-34. PMC: 4483251. DOI: 10.1007/s00134-015-3899-6. View

11.

Seymour C, Rosengart M . Septic Shock: Advances in Diagnosis and Treatment. JAMA. 2015; 314(7):708-17. PMC: 4646706. DOI: 10.1001/jama.2015.7885. View

12.

Venkatesh B, Cohen J . The utility of the corticotropin test to diagnose adrenal insufficiency in critical illness: an update. Clin Endocrinol (Oxf). 2014; 83(3):289-97. DOI: 10.1111/cen.12702. View

13.

Venkatesh B, Cohen J . Adrenocortical (dys)function in septic shock - a sick euadrenal state. Best Pract Res Clin Endocrinol Metab. 2011; 25(5):719-33. DOI: 10.1016/j.beem.2011.04.007. View

14.

Annane D, Sebille V, Troche G, Raphael J, Gajdos P, Bellissant E . A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000; 283(8):1038-45. DOI: 10.1001/jama.283.8.1038. View

15.

Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View

16.

Sprung C, Annane D, Keh D, Moreno R, Singer M, Freivogel K . Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358(2):111-24. DOI: 10.1056/NEJMoa071366. View

17.

Moran J, Graham P, Rockliff S, Bersten A . Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care. 2010; 14(4):R134. PMC: 2945102. DOI: 10.1186/cc9182. View

18.

Cicarelli D, Edson Vieira J, Bensenor F . Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007; 125(4):237-41. PMC: 11020550. DOI: 10.1590/s1516-31802007000400009. View

19.

Bollaert P, Charpentier C, Levy B, Debouverie M, Audibert G, LARCAN A . Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998; 26(4):645-50. DOI: 10.1097/00003246-199804000-00010. View

20.

Goodwin J, Feng Y, Velazquez H, Sessa W . Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A. 2012; 110(1):306-11. PMC: 3538225. DOI: 10.1073/pnas.1210200110. View